Page 122 - Human Use News Today

According to Technical Standard 37 Version 5-2016 on the Sanitary Registration of Medical Devices, a Medical Device for Human Use is understood as any…

STOCKHOLM, Aug. 11, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (NASDAQ Stockholm: ONCO), a biotech company focused on research and development of the

(NASDAQ Stockholm: ONCO), a biotech company focused on research and development of therapies for...

ZTALMY® can now be prescribed by healthcare professionals in the U.S.Second generation ganaxolone formulation demonstrates encouraging results in Phase 1 study in healthy volunteers and supports further clinical developmentMarinus’ Phase 2 refractory status epilepticus (RSE) trial data published in Epilepsia in June...

- NULIBRY is the first and only approved therapy in the United States (U.S.) and in Israel to treat patients with MoCD Type A, an ultra-rare, life...

The CHMP issues a positive recommendation for Roches cancer drug Avastin for use in first-line therapy of advanced renal cell carcinoma

SHELTON, CT / ACCESSWIRE / August 9, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines

Abstract Registered nurses need to be prepared to understand and engage with research as part of core NHS business. This article – the first in a series

During a call to discuss Q2 financials, the company reported a 13 percent year-over-year decrease in Rubraca revenues and said it is exploring strategies to raise additional capital.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.